Literature DB >> 21155387

Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.

H Abdelkader1, S Ismail, A Kamal, R G Alany.   

Abstract

Recent reports have demonstrated that topical and systemic application of naltrexone markedly improves the characteristic signs of diabetic keratopathy; most notably, impaired corneal sensation and delayed wound repair. The aim of this study was to prepare and characterise non-ionic surfactant vesicles (niosomes) for the ocular drug delivery of naltrexone hydrochloride. The niosomes were prepared using the thin film hydration method and characterised using polarized light microscopy, cryo-scanning electron microscopy (Cryo-SEM), percent drug entrapment efficiency (EE %), laser light diffraction and differential scanning calorimetry (DSC). Two classes of non-ionic surfactants (sorbitan esters and polyoxyethylene alkyl ethers) were investigated. The results revealed that tuning of cholesterol concentrations can significantly alter the niosome's physical properties including sizes, EE% and membrane fluidity (thermo-responsiveness). The prepared vesicles were in the range of 7.0 +/- 1.0 to 14.6 +/- 0.8 microm in size. The prepared niosomes showed different abilities to accommodate cholesterol. This was highly dependent on the structure and continuity of the hydrophobic chains of the used surfactants. Span 60-based vesicles containing 30% mol/mol of cholesterol showed the highest EE%. The microstructure and lamellarity of the niosomes were studied using Cryo-SEM. Typical concentric multilayered structures (onion or rose-like) were seen suggesting the formation of multilamellar vesicles. DSC-studies conducted on Span 60-based niosomes containing 30% mol/mol cholesterol revealed liquid-gel transition (T(m) and entropy of 43.5 degrees C and 0.82 kcal/mol, respectively). Such transition reflects potential thermo-responsive properties, which is desirable for ocular delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21155387

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  6 in total

1.  Low-Frequency Sonophoresis as an Active Approach to Potentiate the Transdermal Delivery of Agomelatine-Loaded Novasomes: Design, Optimization, and Pharmacokinetic Profiling in Rabbits.

Authors:  Mai Ahmed Tawfik; Magdy Ibrahim Mohamed; Mina Ibrahim Tadros; Sara Nageeb El-Helaly
Journal:  AAPS PharmSciTech       Date:  2021-10-27       Impact factor: 3.246

2.  Response Surface Optimization of Ultra-Elastic Nanovesicles Loaded with Deflazacort Tailored for Transdermal Delivery: Accentuated Bioavailability and Anti-Inflammatory Efficacy.

Authors:  Adel A Ali; Amira H Hassan; Essam M Eissa; Heba M Aboud
Journal:  Int J Nanomedicine       Date:  2021-01-25

3.  Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.

Authors:  Diana Edwar Aziz; Aly Ahmed Abdelbary; Abdelhalim Ibrahim Elassasy
Journal:  Curr Drug Deliv       Date:  2018       Impact factor: 2.565

4.  Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.

Authors:  Rofida Albash; Mohamed A El-Nabarawi; Hanan Refai; Aly A Abdelbary
Journal:  Int J Nanomedicine       Date:  2019-08-15

Review 5.  Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives.

Authors:  Ranjan Ku Sahoo; Nikhil Biswas; Arijit Guha; Nityananda Sahoo; Ketousetuo Kuotsu
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

6.  Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.

Authors:  Nagwa Hussein Fouda; Randa Tag Abdelrehim; Doaa Abdelmagid Hegazy; Basant Ahmed Habib
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.